Journal article icon

Journal article

Vaccination against GIP for the treatment of obesity.

Abstract:

BACKGROUND: According to the WHO, more than 1 billion people worldwide are overweight and at risk of developing chronic illnesses, including cardiovascular disease, type 2 diabetes, hypertension and stroke. Current therapies show limited efficacy and are often associated with unpleasant side-effect profiles, hence there is a medical need for new therapeutic interventions in the field of obesity. Gastric inhibitory peptide (GIP, also known as glucose-dependent insulinotropic polypeptide) has ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1371/journal.pone.0003163

Authors


Publisher:
Public Library of Science
Journal:
PloS one More from this journal
Volume:
3
Issue:
9
Pages:
e3163
Publication date:
2008-01-01
DOI:
EISSN:
1932-6203
ISSN:
1932-6203
Language:
English
Keywords:
UUID:
uuid:cbef526f-e78a-47b6-9928-beb9bf8f6414
Local pid:
pubs:422404
Source identifiers:
422404
Deposit date:
2014-06-17

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP